Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lambert-Zechovsky, N., Bingen, E., Aujard, Y., & Mathieu, H. (1985). Impact of cefotaxime on the fecal flora in children. Infection, 13 Suppl 1, S140-4.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, clinical sources (sputum, blood - CCUG), soil, water and spoilt food
DNA G+C(%): 59-61
|
Opt. T: 25-30℃
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: R(MIC50): >32, MIC90: >32, RNG: (1->32)
ampicillin: Res
carbenicil: R(>32/>512)
piper-taz: Sens
ertapenem: Var(MIC50): >8, MIC90: >16, RNG: (≤0.008->16)
imipenem: Var(MIC50): >1, MIC90: >16, RNG: (0.12->16)
|
cefaclor: R(32/-)
cefalexin: R(32/-)
cefazolin: Sens
cefdinir: RNG: (>16)
cefepime: Sens
cefixime: R(>32/>32)
cefoperazone: R(32/128)
cefoxitin: Sens
cefpodoxime: Sens
ceftazidime: Sens
cefuroxime: Sens
cephalothin: Sens
moxalactam: R(MIC50): >32, MIC90: >128, RNG: (0.12->128)
|
gentamicin: Sens
tobramycin: Sens
|
|
ciprofloxacin: S(MIC50): 0.25, MIC90: 1, RNG: (≤0.008->16)
clinafloxacin: S(0.12/2)
levofloxacin: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
oxytetracycline: R(40)
tetracycline: Res
|
|
|
nitrofurantoin: Sens
SXT: Sens
|
|